CVS Health Corporation (ETR:CVS)
Germany · Delayed Price · Currency is EUR | Market Cap | 87.63B |
| Revenue (ttm) | 333.84B |
| Net Income (ttm) | 399.73M |
| Shares Out | n/a |
| EPS (ttm) | 0.32 |
| PE Ratio | 219.23 |
| Forward PE | 11.60 |
| Dividend | 2.36 (3.44%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 2 |
| Average Volume | 356 |
| Open | 67.97 |
| Previous Close | 68.56 |
| Day's Range | 67.97 - 67.97 |
| 52-Week Range | 47.04 - 73.65 |
| Beta | n/a |
| RSI | 50.94 |
| Earnings Date | Feb 4, 2026 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
There's an opportunity for CVS Health to keep delivering, says JPMorgan's Lisa Gill
JPMorgan's Lisa Gill joins 'Mad Money' host Jim Cramer to preview the JPMorgan Healthcare conference.
CVS Health to hold fourth quarter and full year 2025 earnings conference call
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.
Dividend Roundup: CVS, MetLife, AT&T, Verizon, and more
Get the latest dividend updates, increases, and upcoming ex-dividend dates for major stocks here.
Here are Evercore ISI's best stock picks for 2026
Evercore singled out several stocks that could offer big returns this year, including Delta Airlines and CVS Health, among other names.
Can These Dividend Stocks Beat the Market Again in 2026?
Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.
Upcoming Dividend Run For CVS?
This morning a "Potential Dividend Run Alert" went out for CVS Health Corporation (NYSE: CVS), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situa...
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are
A new report investigates how the three ... Full story available on Benzinga.com
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are
A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) — ar...
Cigna, CVS pare gains after Hunterbrook Media negative report
CVS (CVS) Maintains Quarterly Dividend of $0.665 Per Share
CVS (CVS) Maintains Quarterly Dividend of $0.665 Per Share
CVS declares $0.665 dividend
CVS Health declares quarterly dividend
WOONSOCKET, R.I. , Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ( $0.665 cents) pe...
CVS Health declares quarterly dividend
WOONSOCKET, R.I., Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per sh...
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
Novo Nordisk A/S (NYSE: NVO) on Monday said the Wegovy pill is now available, which was approved in December 2025 . Novo Nordisk stock is charging ahead with explosive momentum. What’s fueling NVO mo...
CVS Health (CVS) Poised for Continued Growth in 2026
CVS Health (CVS) Poised for Continued Growth in 2026
CVS, Astra, Cardinal to continue record setting rally into 2026: Barron’s
CVS Health (CVS) stock, AstraZeneca)AZN) stock and Cardinal Health (CAH) stock in focus as Barron's expect thier 2025 rally to continue into new year. Read more here.
These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year.
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Peering Into CVS Health Corp's Recent Short Interest
CVS Health Corp's (NYSE: CVS) short interest as a percent of float has risen 17.31% since its last report. According to exchange reported data, there are now 22.92 million shares sold short , which i...
These stocks had big turnarounds in 2025. Where analysts see them heading in 2026
Advanced Micro Devices and CVS Health are two stocks that recovered in 2025 and could still have more room to run higher.
CVS Health (CVS) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw CVS Health (CVS) settling at $79.12, representing a +1.38% change from its previous close.
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now
These top healthcare companies all have strong underlying businesses. Their low valuations can make them attractive for bargain hunters.
2 Dividend Stocks to Buy for 2026 and Beyond
CVS Health is slowly righting the ship after several challenging years. Abbott Laboratories' strong business should improve thanks to an acquisition.
CVS: JP Morgan Raises Price Target and Maintains Overweight Rating | CVS Stock News
CVS: JP Morgan Raises Price Target and Maintains Overweight Rating | CVS Stock News
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Hea...